References
- Fragouli E , AlfarawatiS, DaphnisDDet al. Cytogenetic analysis of human blastocysts with the use of FISH, CGH and aCGH: scientific data and technical evaluation. Hum. Reprod.26(2), 480–490 (2011).
- Kirkegaard K , HindkjaerJJ, IngerslevHJ. Human embryonic development after blastomere removal: a time-lapse analysis. Hum. Reprod.27(1), 97–105 (2012).
- Munne S , GianaroliL, Tur-KaspaIet al. Substandard application of preimplantation genetic screening may interfere with its clinical success. Fertil. Steril.88(4), 781–784 (2007).
- Scott RT Jr , UphamKM, FormanEJ, ZhaoT, TreffNR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil. Steril.100(3), 624–630 (2013).
- Palini S , GalluzziL, De StefaniSet al. Genomic DNA in human blastocoele fluid. Reprod. Biomed. Online26(6), 603–610 (2013).
- Gianaroli L , MagliMC, PomanteAet al. Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study. Fertil. Steril.102(6), 1692–1699 (2014).
- Herrera C , MorikawaMI, CastexCBet al. Blastocele fluid from in vitro- and in vivo-produced equine embryos contains nuclear DNA. Theriogenology83(3), 415–420 (2015).
- Stigliani S , AnseriniP, VenturiniPL, ScaruffiP. Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation. Hum. Reprod.28(10), 2652–2660 (2013).
- Stigliani S , PersicoL, LagazioC, AnseriniP, VenturiniPL, ScaruffiP. Mitochondrial DNA in day 3 embryo culture medium is a novel, non-invasive biomarker of blastocyst potential and implantation outcome. Mol. Hum. Reprod.20(12), 1238–1246 (2014).
- Ueland PM , HustadS, SchneedeJ, RefsumH, VollsetSE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci.22(4), 195–201 (2001).
- D'Alessandro A , FedericaG, PaliniS, BullettiC, ZollaL. A mass spectrometry-based targeted metabolomics strategy of human blastocoele fluid: a promising tool in fertility research. Mol. Biosyst.8(4), 953–958 (2012).
- Abbate R , SardiI, PepeGet al. The high prevalence of thermolabile 5–10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb. Haemost.79(4), 727–730 (1998).
- Zappacosta B , RomanoL, PersichilliSet al. Genotype prevalence and allele frequencies of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Italian newborns. Labmedicine40(12), 732–736 (2009).
- Cao YL , XuJH, ZhangZFet al. Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis. Gene514(2), 105–111 (2013).
- Zheng YM , WangN, LiL, JinF. Whole genome amplification in preimplantation genetic diagnosis. J. Zhejiang. Univ. Sci. B12(1), 1–11 (2011).
- Ihle MA , FassunkeJ, KonigKet al. Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations. BMC Cancer14, 13 (2014).
- Hindson BJ , NessKD, MasquelierDAet al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem.83(22), 8604–8610 (2011).
- Wu H , DingC, ShenXet al. Medium-based noninvasive preimplantation genetic diagnosis for human alpha-thalassemias-SEA. Medicine (Baltimore)94(12), e669 (2015).
- Harton G , BraudeP, LashwoodAet al. ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum. Reprod.26(1), 14–24 (2011).